115 related articles for article (PubMed ID: 18855536)
1. Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease.
Nieminen T; Kähönen M; Viiri LE; Grönroos P; Lehtimäki T
Pharmacogenomics; 2008 Oct; 9(10):1475-86. PubMed ID: 18855536
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
[TBL] [Abstract][Full Text] [Related]
3. Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E epsilon4-carrying free-living individuals.
Loktionov A; Scollen S; McKeown N; Bingham SA
Br J Nutr; 2000 Dec; 84(6):885-90. PubMed ID: 11177205
[TBL] [Abstract][Full Text] [Related]
4. Association of apolipoprotein E genotypes with lipid levels and coronary risk.
Bennet AM; Di Angelantonio E; Ye Z; Wensley F; Dahlin A; Ahlbom A; Keavney B; Collins R; Wiman B; de Faire U; Danesh J
JAMA; 2007 Sep; 298(11):1300-11. PubMed ID: 17878422
[TBL] [Abstract][Full Text] [Related]
5. Identification of genetic variants associated with response to statin therapy.
Mega JL; Morrow DA; Brown A; Cannon CP; Sabatine MS
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1310-5. PubMed ID: 19667110
[TBL] [Abstract][Full Text] [Related]
6. Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease.
Lin Y; Yang Q; Liu Z; Su B; Xu F; Li Y; Kang J; Zhou Z
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209166
[TBL] [Abstract][Full Text] [Related]
7. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus.
Tavintharan S; Lim SC; Chan YH; Sum CF
Diabetes Obes Metab; 2007 Jan; 9(1):81-6. PubMed ID: 17199722
[TBL] [Abstract][Full Text] [Related]
9. [Polymorphisms Ser447Ter of lipoprotein-lipase gene, Cys112Arg and Arg158Cys of apolipoprotein E gene in patients with obesity].
Kirillova OO; Vorozhko IV; Gapparova KM; Chekhonina IuG; Sentsova TB; Tutel'ian VA
Vopr Pitan; 2013; 82(4):4-9. PubMed ID: 24340925
[TBL] [Abstract][Full Text] [Related]
10. [Association of apolipoprotein E gene polymorphism with early-onset coronary heart disease and its effect on plasma lipid levels].
Peng S; Peng J; Gong W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):375-8. PubMed ID: 11592046
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E polymorphism and changes in serum lipids during a family-based counselling intervention.
Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
Public Health Nutr; 2006 Oct; 9(7):859-65. PubMed ID: 17010251
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants.
Volcik KA; Barkley RA; Hutchinson RG; Mosley TH; Heiss G; Sharrett AR; Ballantyne CM; Boerwinkle E
Am J Epidemiol; 2006 Aug; 164(4):342-8. PubMed ID: 16760224
[TBL] [Abstract][Full Text] [Related]
13. Lipid profile and apolipoprotein E polymorphism in essential hypertension.
Bhavani AB; Sastry KB; Reddy NK; Padma T
Indian Heart J; 2005; 57(2):151-7. PubMed ID: 16013355
[TBL] [Abstract][Full Text] [Related]
14. Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype.
Ilveskoski E; Lehtimäki T; Laaksonen R; Janatuinen T; Vesalainen R; Nuutila P; Laippala P; Karhunen PJ; Knuuti J
Scand J Clin Lab Invest; 2007; 67(7):723-34. PubMed ID: 17852827
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E polymorphism and coronary heart disease.
Ashavaid TF; Todur SP; Nair KG
J Assoc Physicians India; 2003 Aug; 51():784-8. PubMed ID: 14651139
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters.
Jemaa R; Elasmi M; Naouali C; Feki M; Kallel A; Souissi M; Sanhaji H; Hadj Taïeb S; Souheil O; Kaabachi N
Clin Biochem; 2006 Aug; 39(8):816-20. PubMed ID: 16714010
[TBL] [Abstract][Full Text] [Related]
17. Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein.
Chasman DI; Kozlowski P; Zee RY; Kwiatkowski DJ; Ridker PM
Genes Immun; 2006 Apr; 7(3):211-9. PubMed ID: 16511556
[TBL] [Abstract][Full Text] [Related]
18. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
19. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
Rump P; Mensink RP; Hornstra G
Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
[TBL] [Abstract][Full Text] [Related]
20. HMGCR and ApoE mutations may cause different responses to lipid lowering statin therapy.
Kirac D; Bayam E; Dagdelen M; Gezmis H; Sarikaya S; Pala S; Altunok EC; Genc E
Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):43-48. PubMed ID: 29096742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
